Öğr. Gör. Dr. NEVİN BELDER

Yayın Ağı

Makaleler 18

1. Repression of Septin9 inhibits the oncogenic phenotype of bladder cancer

VAROL N., BELDER N., ÇETİN S., Durgut S. G., Yildiz H., POLAT F., et al.

Urologic Oncology: Seminars and Original Investigations , 2026 (SCI-Expanded, Scopus)

2. Neuron-derived extracellular vesicles reflect adaptive neuronal responses to cortical spreading depolarization: a biomarker study for migraine

Sever-Bahcekapili M., Cakir-Aktas C., GÜLER Ü., Onat B., Solgun B., Şahin M., et al.

Journal of Headache and Pain , cilt.26, sa.1, 2025 (SCI-Expanded, Scopus)

3. Transformative insights from transcriptome analysis of colorectal cancer patient tissues: identification of four key prognostic genes

BELDER N., Charyyeva S., Oruc E. E. A., Kawalya H., Sahar N., Omidvar N., et al.

PeerJ , 2025 (SCI-Expanded, Scopus)

4. Spreading depolarization triggers pro- and anti-inflammatory signalling: a potential link to headache

Kaya Z., BELDER N., SEVER BAHÇEKAPILI M., ERDENER Ş. E., Donmez-Demir B., Bagci C., et al.

BRAIN , cilt.148, sa.7, ss.2522-2536, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

5. Targeting LINC00152 activates cAMP/Ca²⁺/ferroptosis axis and overcomes tamoxifen resistance in ER plus breast cancer

Saatci O., Alam R., Huynh-Dam K., Isik A., ÜNER M., BELDER N., et al.

CELL DEATH & DISEASE , cilt.15, sa.6, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

6. Prognostic implications of MXRA8 expression in colorectal cancer and its role in tumor progression

BELDER N.

Hacettepe Journal of Biology and Chemistry , cilt.52, 2024 (TRDizin)

7. Transcriptome Analysis of Beta-Catenin-Related Genes in CD34+ Haematopoietic Stem and Progenitor Cells from Patients with AML

Gunes B., Ozkan T., Gurel A. K., Dalkilic S., Belder N., Ozkeserli Z., et al.

MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES , cilt.16, sa.1, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

8. Reduced folate carrier 1 is present in retinal microvessels and crucial for the inner blood retinal barrier integrity

Gurler G., BELDER N., BEKER M. Ç., Sever-Bahcekapili M., Uruk G., Kilic E., et al.

Fluids and Barriers of the CNS , cilt.20, sa.1, 2023 (SCI-Expanded, Scopus)

9. Vesicular HMGB1 release from neurons stressed with spreading depolarization enables confined inflammatory signaling to astrocytes

Kaya Z., Belder N., Sever-Bahcekapili M., Donmez-Demir B., Erdener Ş. E., Bozbeyoglu N., et al.

JOURNAL OF NEUROINFLAMMATION , cilt.20, sa.1, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

10. Overview of extracellular vesicle characterization techniques and introduction to combined reflectance and fluorescence confocal microscopy to distinguish extracellular vesicle subpopulations

Bagci C., SEVER BAHÇEKAPILI M., BELDER N., Bennett A. P. S., ERDENER Ş. E., DALKARA T.

NEUROPHOTONICS , cilt.9, sa.2, 2022 (SCI-Expanded, Scopus)

11. A Stemness and EMT Based Gene Expression Signature Identifies Phenotypic Plasticity and is A Predictive but Not Prognostic Biomarker for Breast Cancer

Akbar M. W., Isbilen M., BELDER N., Demirkol Canli S., Kucukkaraduman B., Turk C., et al.

JOURNAL OF CANCER , cilt.11, sa.4, ss.949-961, 2020 (SCI-Expanded, Scopus)

12. Targeting breast cancer stem cells

Akbar M. W., Isbilen M., BELDER N., Demirkol S., Kucukkaraduman B., Sahin O., et al.

FEBS OPEN BIO , cilt.9, ss.320-321, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

13. Reactivation of cAMP Pathway by PDE4D Inhibition Represents a Novel Druggable Axis for Overcoming Tamoxifen Resistance in ER-positive Breast Cancer

Mishra R. R., BELDER N., Ansari S. A., Kayhan M., Bal H., Raza U., et al.

CLINICAL CANCER RESEARCH , cilt.24, sa.8, ss.1987-2001, 2018 (SCI-Expanded, Scopus)

14. The effect of biological heterogeneity on R-CHOP treatment outcome in diffuse large B-cell lymphoma across five international regions

Carr R., ÖZDAĞ SEVGİLİ H., Tekin N., Morris T., Conget P., Bruna F., et al.

LEUKEMIA & LYMPHOMA , cilt.58, sa.5, ss.1178-1183, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

15. Protocol for qRT-PCR analysis from formalin fixed paraffin embedded tissue sections from diffuse large b-cell lymphoma: Validation of the six-gene predictor score

Tekin N., Omidvar N., Morris T. P., Conget P., Bruna F., Timar B., et al.

ONCOTARGET , cilt.7, sa.50, ss.83319-83329, 2016 (SCI-Expanded, Scopus)

16. From RNA isolation to microarray analysis: Comparison of methods in FFPE tissues.

BELDER N., Coskun Ö., DOĞANAY ERDOĞAN B., İLK DAĞ Ö., SAVAŞ B., ENSARİ A., et al.

Pathology, research and practice , cilt.212, sa.8, ss.678-85, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

17. Optimization of gene expression microarray protocol for formalin-fixed paraffin-embedded tissues.

BELDER N., Coskun Ö., DOĞANAY ERDOĞAN B., SAVAŞ B., ENSARİ A., ÖZDAĞ SEVGİLİ H.

Genomics data , cilt.7, ss.303-6, 2016 (Hakemli Dergi)

18. A neonate with contiguous deletion syndrome in XP21

Sevim U., Fatma D., Ihsan E., Gulay C., Nevin B.

Journal of Pediatric Endocrinology and Metabolism , cilt.24, sa.11-12, ss.1095-1098, 2011 (SCI-Expanded, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 38

1. Chronic Inflammation Response In Acute Myeloid Leukemia (AML)

COŞKUN Ö., Bay M., BELDER N., ÖZDEMİR SAKA C.

8th International Eurasian Conference on Biological and Chemical Sciences (EurasianBioChem 2025), 17 Aralık 2025, (Özet Bildiri)

2. Comprehensive analysis of lysyl oxidase family gene expression and prognostic significance in colorectal cancer

Özdemir I., BELDER N.

1st Regional SDIR-HDIR-MOKAD Congress, Sırbistan, 08 Ekim 2025, (Özet Bildiri)

3. Dual signature role of INHBA and DDIT4 as biomarkers and therapeutic targets in colorectal cancer

BELDER N., DEMİRKOL CANLI S., TAMAM S., ÇULCU S., Göktuna İ. S., YILMAZ E., et al.

49th FEBS Congress, 05 Temmuz 2025, (Özet Bildiri)

4. Deciphering the Molecular Connection Between Ulcerative Colitis and Colorectal Cancer via Integrative Bioinformatic Analysis.

BELDER N.

X. Multidisciplinary Cancer Research Congress, Eskişehir, Türkiye, 08 Mayıs 2025, (Özet Bildiri)

5. Lithium Chloride Suppresses Colorectal Cancer Cell Survival and EMT via GSK3β Inhibition

COŞKUN Ö., BELDER N., ÖZDEMİR SAKA C.

7th International Eurasian Conference on Biological and Chemical Sciences (EurasianBioChem 2024), 02 Ekim 2024, (Özet Bildiri)

6. The predicted biomarkers hsa-miR-1249-5p and hsa-miR-320b via the common target gene PROK2 in β-cell apoptosis in T1DM

KILIÇ P., BELDER N., Coşar B., Savran B. N.

ISOPS 2024, Türkiye, 25 Haziran 2024, (Özet Bildiri)

7. The Role of Exosomes in Promoting Epithelial-to-Mesenchymal Transition in Cancer

BELDER N.

10. ULUSLARARASI ANKARA BİLİMSEL ARAŞTIRMALAR  KONGRESİ, Türkiye, 25 Haziran 2024, (Özet Bildiri)

8. The predicted biomarkers hsa-miR-1249-5p and hsa-miR-320b via the common target gene PROK2 in b-cell apoptosis in T1D

Kılıç P., Belder N., Coşar B., Savran B. N.

ISOPS 2024 , Ankara, Türkiye, 25 - 28 Haziran 2024, ss.0-2, (Özet Bildiri)

9. Increased Expression of DNA Damage Inducible Transcript 4 Gene is Associated with Poor Prognosis and “Right-Sidedness” in Colorectal Cancer

demir f. g., TAMAM S., ÇULCU S., SAVAŞ B., AKBULUT H., ÖZDAĞ SEVGİLİ H., et al.

How to bring basic science discoveries to the clinic, 27 Şubat 2024, (Tam Metin Bildiri)

10. Diagnostic significance and prognostic role of GTSE1 gene in cancer

Demir F. G., ÖZDAĞ SEVGİLİ H., BELDER N.

18. Tıbbi Biyoloji ve Genetik Kongresi, Türkiye, 26 Ekim - 29 Kasım 2023, cilt.2, ss.126, (Özet Bildiri)

11. INHBA is a potential biomarker and therapeutic target for patients with colorectal cancer

BELDER N., DEMİRKOL CANLI S., TAMAM S., ÇULCU S., SAVAŞ B., AKBULUT H.

November 29 – December 02, 2023 9 th International BAU Drug Design Congress, 29 Kasım - 02 Aralık 2023, (Tam Metin Bildiri)

12. Hsa-mir-144-3p/hsa-mir-30d-5p: Ortak Dmxl2 Üzerinden, Diyabet ve Eşlik Eden Nöropati İçin Biyobelirteç Paneli Olabilir Mi?

Kılıç P., Belder N., Coşar B., Oruç F.

22. Uluslararası Katılımlı Ulusal Biyoteknoloji Kongresi, Ankara, Türkiye, 20 - 22 Ekim 2023, (Özet Bildiri)

13. İndirgenmiş folat taşıyıcısı 1 kan-beyin bariyeri bütünlüğünü düzenlemektedir

Gürler G., Soylu K. O., SEVER BAHÇEKAPILI M., BELDER N., KARATAŞ KURŞUN H., Bolbos R., et al.

20. Ulusal Sinirbilim Kongresi, Türkiye, 19 Ekim 2022, (Özet Bildiri)

14. MOLECULAR BIOMARKERS AND PRECISION MEDICINE FOR THE MANAGEMENT OF COLORECTAL CANCER

Belder N.

VI-INTERNATIONAL EUROPEAN CONFERENCE ON INTERDISCIPLINARY SCIENTIFIC RESEARCH, Bucuresti, Romanya, 26 - 27 Ağustos 2022, ss.142, (Özet Bildiri)

15. Integrated analysis of copy number variation and genome-wide expression profiling in colorectal cancer

BELDER N., Sümer Çelebi H., Sümer Çelebi H., SAVAŞ B., ENSARİ A., KUZU M. A., et al.

2nd International Multidisciplinary Cancer Research Congress, Giresun, Türkiye, 21 Temmuz 2022, (Özet Bildiri)

16. CNS CAPILLARY PERICYTES EXPRESS MRNA OF CARDINAL CONTRACTILE PROTEINS, α-SMA AND MYH11: AN IN-SITU HYBRIDIZATION STUDY

Başaran M. D., BELDER N., KÜRELİ G., ERDENER Ş. E., DALKARA T.

FENS Forum 2022, Paris, Fransa, 09 Temmuz 2022, (Özet Bildiri)

17. MODULATING REDUCED FOLATE CARRIER 1 GENE EXPRESSION CHANGES BLOOD-RETINA BARRIER IN HEALTHY AND ISCHEMIC MICE RETINA

Gürler G., BELDER N., Beker M., SEVER BAHÇEKAPILI M., Uruk G., KILIÇ E., et al.

FENS Forum 2022, Paris, Fransa, 09 Temmuz 2022, (Özet Bildiri)

18. Reduced Folate Carrier-1 is expressed in cerebral pericytes and might have a role in ischemia

Gürler G., BELDER N., SEVER BAHÇEKAPILI M., Uruk G., KARATAŞ KURŞUN H., YEMİŞCİ ÖZKAN M.

BRAIN & BRAIN PET 2022, Glasgow, İngiltere, 29 Mayıs 2022, ss.105, (Özet Bildiri)

19. The Role of NUDT6 and S100A9 as New Molecular Players in Hippocampus, Basolateral Amygdala and Prefrontal Cortex in a Post-Traumatic Stress Disorder (PTSD) Model

Uzay B., Belder N., Eren Koçak E.

2022 SOBP, Louisiana, Amerika Birleşik Devletleri, 28 Nisan 2022, ss.337-338, (Özet Bildiri)

20. İndirgenmiş Folat Taşıyıcısı 1 Proteini Kan-Retina Bariyerinde İfade Edilmektedir ve Retinal İskemide Rolü Olabilir

Gürler G., Uruk G., BELDER N., YEMİŞCİ ÖZKAN M.

19. Ulusal Sinirbilim Kongresi, 21 Kasım 2021, (Özet Bildiri)

21. Identification of the Cellular Origin of Brain-Derived Exosomes by Combined Reflectance and Fluorescence Microscopy

BAĞCI C., BELDER N., SEVER BAHÇEKAPILI M., ERDENER Ş. E., DALKARA T.

Neuroscience 2021, 08 Kasım 2021, (Özet Bildiri)

22. BIOINFORMATICS ANALYSIS REVEALS CYCLIN-DEPENDENT KINASE-6 AS A CANDIDATE PROGNOSTIC BIOMARKER IN COLORECTAL CANCER

BELDER N.

1. ULUSLARARASI ONKOLOJIK ACILLER KONGRESI, 07 Ekim 2021, (Özet Bildiri)

23. Identification of a potential four‑gene signature-based risk assessment model to predict prognosis in colorectal cancer patients

BELDER N., Chariyeva S., Kawalya H., Abacı E. E., Namood-e S., SAVAŞ B., et al.

EACR 2021 V􀀊rtual Congress, Amerika Birleşik Devletleri, 09 Haziran 2021, (Özet Bildiri)

24. IDENTIFICATION OF FOUR KEY GENES AS PROMISING PROGNOSTIC BIOMARKERS FOR COLORECTAL CANCER USING INTEGRATIVE ANALYSIS

BELDER N., Abacı E. E., Kawalya H., Namood-e S., SAVAŞ B., ENSARİ A., et al.

8th Multidisciplinary Cancer Research Congress, 15 Ocak 2021, (Özet Bildiri)

25. Reduced Folate Carrier 1 is Present in Cerebral and Retinal Microvessels

Gürler G., Uruk G., BELDER N., YEMİŞCİ ÖZKAN M.

SfN Global Connectom, 11 Ocak 2021, (Özet Bildiri)

26. SPORADİK KOLOREKTAL KANSERDE GLOBAL miRNA ve mRNA İFADE PROFİLLERİNİN ENTEGRASYONU

BELDER N., ÖZDAĞ H., SAVAŞ B., ENSARİ A., KUZU M. A., abacı e. e., et al.

XIII. Ulusal Tıbbi Genetik Kongresi, Türkiye, 07 Kasım 2019 - 11 Kasım 2018, (Özet Bildiri)

27. Trombospodin-2 geni yüksek ifadesinin kolorektal kanserde prognostik etkisi vardır

ÖZDAĞ H., BELDER N., abacı e. e., Kawalya H., Namoode S., SAVAŞ B., et al.

XVI. Tıbbi Biyoloji ve Genetik Kongresi, 27 - 30 Ekim 2019, (Özet Bildiri)

28. Resolution of neuroinflammation triggered by cortical spreading depression

BELDER N., DALKARA T., DEMİR B. N., KARATAŞ KURŞUN H., EREN KOÇAK E., YEMİŞCİ ÖZKAN M., et al.

Society for Neurosciency, 19 - 23 Ekim 2019, (Özet Bildiri)

29. Overcoming tamoxifen resistance and inhibiting metastatic recurrence in estrogen receptor-positive breast cancer

Ersan P. G., Saatci O., Tarman O., Mishra R., BELDER N., Tokat U. M., et al.

Annual Meeting of the American-Association-for-Cancer-Research (AACR), Georgia, Amerika Birleşik Devletleri, 29 Mart - 03 Nisan 2019, cilt.79, (Özet Bildiri) Sürdürülebilir Kalkınma

30. Targeting breast cancer stem cells

Akbar M. W., İşbilen M., BELDER N., DEMİRKOL CANLI S., Küçükkaraduman B., ŞAHİN Ö., et al.

The 45th FEBS Congress, Krakow, Polonya, 6 - 11 Temmuz 2019, cilt.9, ss.320-321, (Özet Bildiri)

31. Targeting long non-coding RNAs (lncRNAs) to overcome tamoxifen resistance in Estrogen Receptor alpha (ERα) positive breast cancer

ŞAHİN Ö., BELDER N., Tarman O., Bal H., Saatçi Ö., Ersan P., et al.

6th International BAU Drug Design Congress, 13 - 15 Aralık 2018, (Özet Bildiri)

32. Genomic meta-analysis and discovery of new biomarkers in colorectal cancer

Kawalya H., BELDER N., KUZU M. A., Savas B., ENSARİ A., ÖZDAĞ SEVGİLİ H.

41st FEBS Congress on Molecular and Systems Biology for a Better Life, Kusadasi, Türkiye, 3 - 08 Eylül 2016, cilt.283, ss.15, (Özet Bildiri)

33. Association between loss of 18q21, gain of 20q13.33 and progression in sporadic colorectal cancer

BELDER N., Savas B., KUZU M. A., Pak I., Celebi H. S., ENSARİ A., et al.

41st FEBS Congress on Molecular and Systems Biology for a Better Life, Kusadasi, Türkiye, 3 - 08 Eylül 2016, cilt.283, ss.142-143, (Özet Bildiri)

34. A meta-analysis for the identification of common microRNA signatures in colorectal cancer

Sahar N., BELDER N., ÖZDAĞ SEVGİLİ H.

41st FEBS Congress on Molecular and Systems Biology for a Better Life, Kusadasi, Türkiye, 3 - 08 Eylül 2016, cilt.283, ss.281, (Özet Bildiri)

35. DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) STUDY REVEALS BIOLOGICAL HETEROGENEITY BETWEEN ETHNICALLY DIVERSE COUNTRIES; VALIDATION OF 6-GENE PROGNOSTIC SCORE IN AN INTERNATIONAL COHORT

Tekin N., Omidvar N., Morris T., Timar B., Gagyi E., Conget P., et al.

21st Congress of the European-Hematology-Association, Copenhagen, Danimarka, 9 - 12 Haziran 2016, cilt.101, ss.579-580, (Özet Bildiri)

36. Second step of genome-wide association study: Validation of 50 single nucleotit polymorphisms associated with sporadic colorectal cancer in Turkish population

Cumaogullari O., Dag O. I., Tekin N., Rajabli F., KUZU M. A., Dungul D. C., et al.

40th Congress of the Federation-of-European-Biochemical-Societies (FEBS) - The Biochemical Basis of Life, Berlin, Almanya, 4 - 09 Temmuz 2015, cilt.282, ss.394, (Özet Bildiri) Sürdürülebilir Kalkınma

37. Transcriptome profiling of colorectal cancer

BELDER N., SAVAŞ B., ENSARİ A., KUZU M. A., ÖZDAĞ SEVGİLİ H.

European Biotechnology Congress, Bratislava, Slovakya, 16 - 18 Mayıs 2013, cilt.24, (Özet Bildiri) Sürdürülebilir Kalkınma

38. Short-term rosiglitazone treatment decreases expression of receptors for advanced glycation end products (RAGE) and proinflammatory cytokines in aortic tissues from AGEs-injected rats

Belder N., Belder M., OZANSOY F. G., ARI N.

European Pharmacology Congress, Manchester, Birleşik Krallık, 13 - 17 Temmuz 2008, cilt.22, ss.101, (Özet Bildiri)

Kitaplar 4

Yayınlar & Eserler